The Lancet: May 01, 2009
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
Robert Pirker discusses the research article about the human monoclonal antibody cetuximab in the treatment of lung cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
